Austria-Israel Bilateral Trade Analysis 2023

Complete trade statistics: $0 total volume •Austria surplus: $0

AustriaIsrael

$0

Exports (2023)

IsraelAustria

$0

Imports (2023)

Trade Balance

$0

Surplus for Austria

Total Trade

$0

Combined Volume

Trade Flow Visualization

Direct trade relationship between Austria and Israel. Green line shows exports from Austria, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Austria-Israel commercial relationship and competitive positioning in global markets.

AustriaIsrael Exports

$0
2023 Total

Export Market Intelligence

Product Diversity:
Specialized Focus
Market Share:
Infinity% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$43.01M
Infinity% of exports
2Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
$39.38M
Infinity% of exports
3Vehicles: compression-ignition internal combustion piston engine (diesel or semi-diesel), for transport of goods, (of a g.v.w. exceeding 5 tonnes but not exceeding 20 tonnes), n.e.c. in item no 8704.1
$18.86M
Infinity% of exports
4Mountings, fittings and similar articles: suitable for furniture of base metal
$18.53M
Infinity% of exports
5Cranes and derricks: designed for mounting on road vehicles
$11.96M
Infinity% of exports

🎯 Strategic Export Focus

Austria's export portfolio to Israel demonstrates strategic specialization, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

IsraelAustria Imports

$0
2023 Total

Import Dependency Profile

Supply Diversity:
Concentrated
Critical Imports:
Infinity% concentration
1Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
$70.85M
Infinity% of imports
2Oils: petroleum oils and oils obtained from bituminous minerals, crude
$40.69M
Infinity% of imports
3Electrical static converters
$15.90M
Infinity% of imports
4Optical instruments and appliances: for inspecting semiconductor wafers or devices or for inspecting photomasks or reticles used in manufacturing semiconductor devices, n.e.c. in chapter 90
$11.99M
Infinity% of imports
5Communication apparatus (excluding telephone sets or base stations): machines for the reception, conversion and transmission or regeneration of voice, images or other data, including switching and routing apparatus
$6.48M
Infinity% of imports

📦 Import Strategy Analysis

Austria's import pattern from Israel reveals strategic sourcingin blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

🏆

Market Leadership

Austria demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Israel, leveraging comparative advantages.

Export Leader in 5+ Categories
🔄

Trade Complementarity

The bilateral relationship showsperfectcomplementarity, with each country specializing in different sectors.

Specialized Exchange
📈

Growth Potential

The $0 trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Significant Partnership

Executive Summary: Austria-Israel Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $0.00representing a significant bilateral economic relationship
  • Trade Balance: Austria maintains a surplus of $0.00
  • Export Focus: Austria's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, vehicles: compression-ignition internal combustion piston engine (diesel or semi-diesel), for transport of goods, (of a g.v.w. exceeding 5 tonnes but not exceeding 20 tonnes), n.e.c. in item no 8704.1
  • Import Dependencies: Key imports from Israel include blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, oils: petroleum oils and oils obtained from bituminous minerals, crude, electrical static converters

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationConcentrated
Trade Balance HealthImbalanced

📈 Market Position: This bilateral trade relationship represents an important regional trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $0 represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Austria leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Austria's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Israel's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $0 bilateral relationship.

Trade Pattern Insights

Trade ComplementarityBalanced
Seasonal VariationsModerate
Product ConcentrationMedium
Market DependencyModerate
🔮

Trade Relationship Outlook

The $0 bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

💰

Trade Volume Impact

The $0.00 bilateral trade volume represents a important trade relationshipfor both economies.

Economic Significance: Moderate
🏭

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Specialized
⚖️

Trade Balance Effects

Austria's trade surplus of $0.00 strengthens its overall economic position in this bilateral relationship.

Balance Impact: Export Advantage

Strategic Future Outlook

🚀Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions present expansion opportunities.
Market Diversification
Beyond current focus on blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, new product categories offer potential for trade expansion.

⚠️Risk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

🎯Strategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Austria and Israel represents a total trade volume of $0.00 in 2023. This partnership demonstrates a favorable trade balance for Austria, with exports exceeding importsby $0.00.

Export Strengths

Austria's exports to Israel total $0.00, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $43.01M orInfinity% of bilateral exports.

Import Dependencies

Imports from Israel amount to $0.00, highlighting economic interdependence in blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, with Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions comprisingInfinity% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Austria's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Austria and Israel in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023